A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailprint

August 19, 2009

New Evidence in Debate Over Treatment as Prevention

People with viral loads less than 50 copies tend to keep their virus suppressed consistently, which lends weight to the argument that such folks are unlikely to pass their infection on to their HIV-negative sex partners, according to a study published in HIV Medicine and reported by aidsmap.

A declaration by Swiss researchers sent a shockwave through the HIV community in January 2008, when they claimed that certain heterosexual people with HIV simply couldn’t pass the virus on to their HIV-negative partners, even in the absence of condom use or other barrier methods. There were some qualifiers: Both partners needed to be sexually monogamous, and neither could have a sexually transmitted infection. Also, the HIV-positive partner needed to be adherent to his or her medication and have had an undetectable viral load for at least six months before engaging in unprotected sexual activity.

A number of studies have, in fact, demonstrated that people with HIV are far less likely to transmit the virus if they have an undetectable viral load, but the Swiss declaration was the first to claim that the risk is essentially nil. One counter-argument raised by critics: People with HIV adhering to antiretroviral (ARV) therapy may experience viral blips, where their virus goes up temporarily. This could, theoretically, increase the risk of transmission if condoms are not being used.

To examine the likelihood of blips, Christophe Combescure, PhD, from the University Hospital Geneva, in Switzerland, and his colleagues from the Swiss HIV Cohort examined data on 6,168 patients who were on ARV therapy and had successive viral load tests between 2003 and 2007. Though the frequency of visits varied, most people had viral load tested once every three months.

Combescure’s team found that when people claimed to have missed no doses of their ARVs in the previous four weeks, they had an 85 percent chance of having their HIV levels remain under 50 copies consistently. Most viral load blips were transient. In people whose virus jumped to between 200 and 1,000 copies—detectable but still associated with a very low risk of HIV transmission—66 percent went back to undetectable at the next test.

This was less true for people whose virus had jumped to more than 1,000 copies—when transmission may be more likely to occur, the authors explain. Just 30 percent of them went back to undetectable. This occurred rarely however. The overall chance that a person would go from undetectable to more than 1,000 copies was just 2 percent, and if a person was on a potent three-drug regimen this dropped to 1 percent.

In the final analysis, poor adherence or an inferior regimen explained most of the viral load increases to more than 1,000 copies. The authors concede, however, that the “data leave open the possibility that unexplained rises in viral load above 1,000 copies/ml, although rare, may occur.”

These data also do not explore the possibility that viral load in the genital compartment may be much higher than in blood, and the impact that may have on infectiousness.

Search: Swiss declaration, viral load, treatment as prevention, consistent viral load


Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 2 (of 2 total)    

Jon makay, nashville, 2010-09-23 17:37:34
Does anyone know of any other studies, full or partially supporting of this? I would like to know this in full about the real risk factors for a Neg top, and Poz Bottom. Any references/citations for newer studies.???

Jeton Ademaj, , 2009-08-20 13:38:29
This is good news, as any innovation in prevention is. 25 years in, there's still a powerful reflex among professionals working with PWA's to condemn any sex that isn't rubbered.

condoms are the new normal of a permanently pathologized gay sexuality...when gay men recoil from permanent condom use, some activists offer NewSpeak. Last week at GMHC 1 asked "how did we convince ourselves that barebacking is somehow NATURAL?"

i lol'd. "the human nervous system did it for us", i replied.

comments 1 - 2 (of 2 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    adoniz89
    san dimas
    California


    Sin_Grinder
    Genoa
    Nevada


    MascVersWPB
    Lake Worth
    Florida


    jdog46948
    Detroit
    Michigan
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.